baclofen has been researched along with Child Development Disorders, Pervasive in 2 studies
Child Development Disorders, Pervasive: Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erickson, CA | 1 |
| Veenstra-Vanderweele, JM | 1 |
| Melmed, RD | 1 |
| McCracken, JT | 1 |
| Ginsberg, LD | 1 |
| Sikich, L | 1 |
| Scahill, L | 1 |
| Cherubini, M | 1 |
| Zarevics, P | 1 |
| Walton-Bowen, K | 1 |
| Carpenter, RL | 1 |
| Bear, MF | 1 |
| Wang, PP | 1 |
| King, BH | 1 |
| Hopkins, CR | 1 |
1 review available for baclofen and Child Development Disorders, Pervasive
| Article | Year |
|---|---|
ACS chemical neuroscience molecule spotlight on STX209 (arbaclofen).
Topics: Animals; Baclofen; Child; Child Development Disorders, Pervasive; Clinical Trials, Phase II as Topic | 2011 |
1 trial available for baclofen and Child Development Disorders, Pervasive
| Article | Year |
|---|---|
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
Topics: Adolescent; Akathisia, Drug-Induced; Baclofen; Child; Child Development Disorders, Pervasive; Female | 2014 |